Ventus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo Nordisk
WALTHAM, Mass. & MONTREAL–(BUSINESS WIRE)–Ventus Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing its proprietary structural... Read more.
GeoPark Publishes Its 2023 SPEED/Sustainability Report
Strong Results in Emissions Reduction Strategy Underpin a Year of Social, Environmental and Governance Achievements 10.6 Kg CO2e/boe Emissions Intensity in 2023... Read more.
Cheniere Partners Reports First Quarter 2024 Results and Reconfirms Full Year 2024 Distribution Guidance
HOUSTON–(BUSINESS WIRE)–Cheniere Energy Partners, L.P. (“Cheniere Partners”) (NYSE: CQP) today announced its financial results for first quarter... Read more.
Cheniere Reports First Quarter 2024 Results and Reconfirms Full Year 2024 Financial Guidance
HOUSTON–(BUSINESS WIRE)–Cheniere Energy, Inc. (“Cheniere”) (NYSE: LNG) today announced its financial results for the first quarter 2024. FIRST QUARTER... Read more.
Real Begins May With More Than 17,000 Agents Following Another Strong Growth Month
Top teams from coast to coast make the move to Real for the flexibility of its technology platform and strong culture TORONTO & NEW YORK–(BUSINESS WIRE)–$REAX... Read more.
Fubo Exceeded Q1 2024 Guidance in North America, Delivering 1.511M Paid Subscribers, $394M Total Revenue
Company Achieved Double Digit Year-over-Year Increases Across Key Performance Metrics in North America, Including 21% Ad Revenue Growth NEW YORK–(BUSINESS... Read more.
Global Blue Announces Repricing of Term Loan and Revolving facility
SIGNY, Switzerland–(BUSINESS WIRE)–Global Blue Group Holding AG (the “Company”) (NYSE:GB) has continued to demonstrate a robust recovery, underpinned... Read more.
Companion Diagnostics Technologies and Global Markets Report 2023-2024 and 2028 Featuring Major Players – F. Hoffmann-La Roche, Agilent Technologies, and QIAGEN – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Companion Diagnostics: Technologies and Markets 2023-2028” report has been added to ResearchAndMarkets.com’s... Read more.
FiscalNote to Present at Upcoming Investor Conferences
WASHINGTON–(BUSINESS WIRE)–FiscalNote Holdings, Inc. (NYSE: NOTE) (“FiscalNote”), a leading AI-driven enterprise SaaS technology provider... Read more.
FiscalNote to Present at Upcoming Investor Conferences
WASHINGTON–(BUSINESS WIRE)–FiscalNote Holdings, Inc. (NYSE: NOTE) (“FiscalNote”), a leading AI-driven enterprise SaaS technology provider... Read more.